wada aod9604 prohibited list status 2025 publishes π New Additions to the
Description
Novel tricyclic small molecule inhibitors of Nicotinamide N-methyltransferase for the treatment of metabolic disorders
The path forward For 5-amino-1mq to move from research compound to established therapy, human clinical trials are needed
In rare cases, allergic reactions (such as hives, swelling, or even anaphylaxis) have been reported
Who should check with a provider first If you are pregnant, nursing, have kidney disease, or take medications that interact with B12 metabolism (such as metformin), discuss this with a provider before starting
Key Features Composition: Contains Methylcobalamin (Vitamin B12) and other vitamins in a sterile solution, formulated for safe administration
